De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Alcon Toekomstige groei

Future criteriumcontroles 2/6

Alcon zal naar verwachting groeien in winst en omzet met respectievelijk 11.2% en 6.3% per jaar. De winst per aandeel zal naar verwachting groeien met 10.8% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 8.3% zijn.

Belangrijke informatie

11.2%

Groei van de winst

10.8%

Groei van de winst per aandeel

Medical Equipment winstgroei	14.9%
Inkomstengroei	6.3%
Toekomstig rendement op eigen vermogen	8.3%
Dekking van analisten	Good
Laatst bijgewerkt	07 Oct 2024

Recente toekomstige groei-updates

Results: Alcon Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Mar 01

Recent updates

Results: Alcon Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Mar 01

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Feb 15

Alcon Inc.'s (VTX:ALC) Business Is Yet to Catch Up With Its Share Price

Dec 22

Returns On Capital Are Showing Encouraging Signs At Alcon (VTX:ALC)

Dec 04

Calculating The Fair Value Of Alcon Inc. (VTX:ALC)

Nov 08

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Oct 18

Alcon (VTX:ALC) Might Have The Makings Of A Multi-Bagger

Aug 25

A Look At The Fair Value Of Alcon Inc. (VTX:ALC)

Aug 10

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Jul 05

Investors Will Want Alcon's (VTX:ALC) Growth In ROCE To Persist

May 12

Does Alcon (VTX:ALC) Have A Healthy Balance Sheet?

Apr 03

Here's Why Alcon (VTX:ALC) Has Caught The Eye Of Investors

Feb 03

Returns Are Gaining Momentum At Alcon (VTX:ALC)

Jan 19

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Dec 18

Do Alcon's (VTX:ALC) Earnings Warrant Your Attention?

Nov 02

Alcon's (VTX:ALC) Returns On Capital Are Heading Higher

Sep 30

We Think Alcon (VTX:ALC) Can Stay On Top Of Its Debt

Sep 11

With Alcon Inc. (VTX:ALC) It Looks Like You'll Get What You Pay For

Aug 26

These 4 Measures Indicate That Alcon (VTX:ALC) Is Using Debt Reasonably Well

Jun 10

Alcon (VTX:ALC) Is Experiencing Growth In Returns On Capital

May 20

There's Been No Shortage Of Growth Recently For Alcon's (VTX:ALC) Returns On Capital

Feb 13

Does Alcon (VTX:ALC) Have A Healthy Balance Sheet?

Dec 28

We Like These Underlying Return On Capital Trends At Alcon (VTX:ALC)

Oct 26

Does Alcon (VTX:ALC) Have A Healthy Balance Sheet?

Sep 15

Winst- en omzetgroeiprognoses

SWX:ALC - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	11,351	1,471	1,750	2,540	17
12/31/2025	10,662	1,180	1,506	2,301	21
12/31/2024	9,945	945	1,311	2,005	21
6/30/2024	9,636	1,102	1,086	1,849	N/A
3/31/2024	9,562	1,048	777	1,644	N/A
12/31/2023	9,455	974	535	1,388	N/A
9/30/2023	9,274	450	525	1,282	N/A
6/30/2023	9,085	362	317	1,157	N/A
3/31/2023	8,880	341	480	1,236	N/A
12/31/2022	8,717	335	-13	1,217	N/A
9/30/2022	8,695	571	-61	1,259	N/A
6/30/2022	8,657	457	-17	1,273	N/A
3/31/2022	8,550	460	-406	1,255	N/A
12/31/2021	8,291	376	165	1,345	N/A
9/30/2021	8,082	332	322	1,397	N/A
6/30/2021	7,818	183	307	1,307	N/A
3/31/2021	6,922	-390	364	949	N/A
12/31/2020	6,833	-531	256	823	N/A
9/30/2020	6,806	-717	132	730	N/A
6/30/2020	6,836	-636	62	677	N/A
3/31/2020	7,525	-604	275	920	N/A
12/31/2019	7,508	-656	244	920	N/A
9/30/2019	7,386	-638	134	800	N/A
6/30/2019	7,280	-779	178	886	N/A
3/31/2019	7,177	-362	178	893	N/A
12/31/2018	7,153	-227	428	1,140	N/A
9/30/2018	7,123	175	697	1,375	N/A
12/31/2017	6,792	256	N/A	1,218	N/A
12/31/2016	6,596	-170	N/A	1,245	N/A
12/31/2015	6,776	308	N/A	1,370	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei ALC ( 11.2% per jaar) ligt boven de spaarquote ( 0.3% ).

Winst versus markt: De winst van ALC ( 11.2% per jaar) zal naar verwachting langzamer groeien dan de markt Swiss ( 11.8% per jaar).

Hoge groeiwinsten: De winst van ALC zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van ALC ( 6.3% per jaar) zal naar verwachting sneller groeien dan de markt Swiss ( 4.4% per jaar).

Hoge groei-inkomsten: De omzet van ALC ( 6.3% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen ALC zal naar verwachting over 3 jaar laag zijn ( 8.3 %).

Alcon Toekomstige groei

Future criteriumcontroles 2/6

Belangrijke informatie

Recente toekomstige groei-updates

Alcon Inc. Maintains Earnings Guidance for the Year 2024

Results: Alcon Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Alcon Inc. Revises Earnings Guidance for the Full Year 2023

Alcon Inc. Raises Earnings Guidance for the Full Year 2023

Alcon Inc. Provides Earnings Guidance for the Year 2023

Alcon Inc. Updates Earnings Guidance for the Year 2022

Recent updates

CEO & Director notifies of intention to sell stock

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Alcon Inc. Maintains Earnings Guidance for the Year 2024

Now 24% undervalued

Investor Optimism Abounds Alcon Inc. (VTX:ALC) But Growth Is Lacking

A Look At The Fair Value Of Alcon Inc. (VTX:ALC)

Alcon's Latest Equipment Breakthrough Technologies, Unity VCS and Unity CS, Receive U.S. FDA 510(k) Clearance

Should You Be Adding Alcon (VTX:ALC) To Your Watchlist Today?

Alcon's (VTX:ALC) Returns On Capital Are Heading Higher

These 4 Measures Indicate That Alcon (VTX:ALC) Is Using Debt Reasonably Well

First quarter 2024 earnings: EPS exceeds analyst expectations

Upcoming dividend of CHF0.24 per share

Alcon Inc. Approves Gross Dividend

Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and Its Hydrus Microstent for Microinvasive Glaucoma Surgery

Dividend of CHF0.24 announced

Alcon Inc.'s (VTX:ALC) Shareholders Might Be Looking For Exit

Alcon Announces Management Changes

Here's Why Alcon (VTX:ALC) Has Caught The Eye Of Investors

Alcon Inc. Launches Clareon Presbyopia Correcting IOLs in India

President of North America notifies of intention to sell stock

Results: Alcon Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Alcon Inc. Proposes Dividend for the Year 2023

Full year 2023 earnings: EPS exceeds analyst expectations

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Alcon Announces Positive Topline Results from Phase 3 Comet Trials of AR-15512, A Novel Topical Drug Candidate for Dry Eye

Alcon Inc.'s (VTX:ALC) Business Is Yet to Catch Up With Its Share Price

Returns On Capital Are Showing Encouraging Signs At Alcon (VTX:ALC)

Alcon Inc., Annual General Meeting, May 08, 2024

Alcon Inc. Revises Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings: EPS exceeds analyst expectations

Calculating The Fair Value Of Alcon Inc. (VTX:ALC)

Alcon Inc. Showcases Cloud-Based Planning and World-Class Digital Technologies During AAO 2023

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Alcon Launches Total30 Multifocal Contact Lenses for Patients with Presbyopia

Alcon (VTX:ALC) Might Have The Makings Of A Multi-Bagger

Alcon Inc. Raises Earnings Guidance for the Full Year 2023

Second quarter 2023 earnings released: EPS: US$0.34 (vs US$0.30 in 2Q 2022)

A Look At The Fair Value Of Alcon Inc. (VTX:ALC)

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Head of Corporate Development notifies of intention to sell stock

Investors Will Want Alcon's (VTX:ALC) Growth In ROCE To Persist

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Alcon Inc. Provides Earnings Guidance for the Year 2023

Alcon Announces Results from a New Study Presented at the American Society of Cataract and Refractive Surgery Annual Meeting

Alcon Inc. Approves Dividend

Upcoming dividend of CHF0.21 per share at 0.3% yield

Does Alcon (VTX:ALC) Have A Healthy Balance Sheet?

Full year 2022 earnings: EPS misses analyst expectations

Now 21% undervalued

Alcon Inc. Announces Settlement of Litigation Related to Femtosecond Laser Assisted Cataract Surgery Devices

Alcon Launches New Total Toric Lenses for Astigmatic Patients

Here's Why Alcon (VTX:ALC) Has Caught The Eye Of Investors

Returns Are Gaining Momentum At Alcon (VTX:ALC)

Alcon Inc., Annual General Meeting, May 05, 2023

Alcon Introduces a Premium, Reusable Toric Lens with Launch of TOTAL30 for Astigmatism

Alcon (VTX:ALC) Has A Pretty Healthy Balance Sheet

Now 20% undervalued

Alcon Inc. Updates Earnings Guidance for the Year 2022

Insufficient new directors

Alcon Inc. Revises Revenue Guidance for 2022

Do Alcon's (VTX:ALC) Earnings Warrant Your Attention?

Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022

Alcon's (VTX:ALC) Returns On Capital Are Heading Higher

We Think Alcon (VTX:ALC) Can Stay On Top Of Its Debt

With Alcon Inc. (VTX:ALC) It Looks Like You'll Get What You Pay For

Alcon Inc. (SWX:ALC) entered into a definitive merger agreement to acquire Aerie Pharmaceuticals, Inc. (NasdaqGM:AERI) for approximately $770 million.

Consensus forecasts updated

Second quarter 2022 earnings: EPS exceeds analyst expectations